Palatin Technologies
PTN
#10051
Rank
C$39.78 M
Marketcap
C$23.37
Share price
-2.27%
Change (1 day)
1,353.87%
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2025 (TTM): -C$6.94 Million

According to Palatin Technologies's latest financial reports the company's current earnings are C$8.84 Million. In 2024 the company made an earning of -C$37.45 Million, an increase over its 2023 earnings that were of -C$45.07 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$6.94 Million-81.48%
2024 -C$37.45 Million-16.9%
2023 -C$45.07 Million5.99%
2022 -C$42.53 Million-13.7%
2021 -C$49.27 Million33.25%
2020 -C$36.98 Million-172.11%
2019 C$51.27 M2352.33%
2018 C$2.09 M-94.13%
2017 C$35.62 M-154.92%
2016 -C$64.87 Million3.67%
2015 -C$62.58 Million878%
2014 -C$6.4 Million-72.64%
2013 -C$23.39 Million-33.11%
2012 -C$34.96 Million77.71%
2011 -C$19.68 Million
2003 -C$33.32 Million29.93%
2002 -C$25.64 Million36.18%
2001 -C$18.83 Million
1999 -C$15.63 Million6.04%
1998 -C$14.74 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
MediciNova
MNOV
-C$16.69 Million 150.36%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-C$41 Million 514.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
C$0.81 B-12,262.47%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
C$70.27 M-1,154.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
C$92.85 M-1,492.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-C$0.17 Billion 2,353.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$45.03 B-675,709.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-C$77.23 Million 1,058.48%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$18.19 B-273,088.15%๐Ÿ‡ฌ๐Ÿ‡ง UK